| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | — | — | — | — | — | — |
| 3d | — | — | — | — | — | — |
| 1w | — | — | — | — | — | — |
| 1m | — | — | — | — | — | — |
| 3m | — | — | — | — | — | — |
| 6m | — | — | — | — | — | — |
| 1y | — | — | — | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
Cinemark is positioned to benefit from the theater revival driven by strong May attendance (26 million guests) and renewed consumer interest in cinema. CNK rose 20% recently, and elevated short volumes suggest potential for further upside as the trend continues.
Theater attendance has surged to pre-covid levels in May 2024 with record domestic and global attendance (26 million guests). Indie horror films are driving a revival in theater-going as audiences tire of franchise content, and AMC has already doubled in price since April amid elevated short volumes, suggesting potential continued upside.
End of results.